Unknown

Dataset Information

0

EPDR1 promotes PD-L1 expression and tumor immune evasion by inhibiting TRIM21-dependent ubiquitylation of IkappaB kinase-b


ABSTRACT: While immune checkpoint blockade (ICB) has shown promise for clinical cancer therapy, its efficacy has only been observed in a limited subset of patients and the underlying mechanisms regulating innate and acquired resistance to ICB of tumor cells remain poorly understood. Here, we identified ependymin-related protein 1 (EPDR1) as an important tumor-intrinsic regulator of PD-L1 expression and tumor immune evasion. Aberrant expression of EPDR1 in hepatocellular carcinoma is associated with immunosuppression. Mechanistically, EPDR1 binds to E3 ligase TRIM21 and disrupts its interaction with IkappaB kinase-, suppressing its ubiquitylation and autophagosomal degradation and enhancing NF-κB-mediated transcriptional activation of PD-L1. Further, we validated through a mouse liver cancer model that EPDR1 mediates exhaustion of CD8+ T cells and promotes tumor progression. In addition, we observed a positive correlation between EPDR1 and PD-L1 expression in both human and mouse liver cancer samples. Collectively, our study reveals a previously unappreciated role of EPDR1 in orchestrating tumor immune evasion and cancer progression.

SUBMITTER: Dr. Xiaoyu Qian 

PROVIDER: S-SCDT-10_1038-S44318-024-00201-6 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

2024-06-29 | GSE250169 | GEO
| S-SCDT-EMBOJ-2018-99506 | biostudies-other
| S-EPMC10107526 | biostudies-literature
| S-EPMC5992436 | biostudies-literature
| S-EPMC6589543 | biostudies-literature
| S-EPMC5954021 | biostudies-literature
2024-01-24 | PXD046384 | Pride
| S-EPMC6287426 | biostudies-other
| S-EPMC10864387 | biostudies-literature
| S-EPMC10291184 | biostudies-literature